» Articles » PMID: 39231933

Eight-year Total, Cognitive-affective, and Somatic Depressive Symptoms Trajectories and Risks of Cardiac Events

Overview
Date 2024 Sep 4
PMID 39231933
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we analyzed pooled data from two prospective population-based cohorts-the Health Retirement Study (HRS) and the English Longitudinal Study of Ageing (ELSA)-to explore the association between trajectories of depressive symptoms and the risk of cardiac events. Depressive symptoms were assessed using the 8-item CES-D scale and categorized into somatic and cognitive-affective subtypes. Trajectories were tracked for four surveys from baseline. Heart disease was identified based on self-reported physician-diagnosed conditions. Hazard ratios and 95% confidence intervals were calculated with Cox proportional risk models that adjusted for potential confounders. In total, 17,787 subjects (59.7% female, median age 63 years) were enrolled at baseline. During a 10-year follow-up, 2409 cases of heart disease were identified. Participants with fluctuating (HR = 1.13, 95% CI: 1.06-1.20), increasing (HR = 1.43, 95% CI: 1.25-1.64), and consistently high (HR = 1.64, 95% CI: 1.45-1.84) depressive symptom trajectories exhibited an increased risk of heart disease compared to those with consistently low depressive symptoms, while a decreasing (HR = 1.07, 95% CI: 0.96-1.19) depressive symptom trajectory did not significantly affect the risk of heart disease. Moreover, the association between heart disease and somatic depressive symptoms was found to be stronger than with cognitive-affective symptoms. These findings suggest a significant link between depressive symptom trajectories and heart disease, with particular emphasis on stronger associations with somatic symptoms. It is recommended that the identification and management of depressive symptoms be incorporated into heart disease prevention strategies.

References
1.
Wadstrom B, Pedersen K, Wulff A, Nordestgaard B . Elevated remnant cholesterol, plasma triglycerides, and cardiovascular and non-cardiovascular mortality. Eur Heart J. 2023; 44(16):1432-1445. DOI: 10.1093/eurheartj/ehac822. View

2.
Tsao C, Aday A, Almarzooq Z, Anderson C, Arora P, Avery C . Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association. Circulation. 2023; 147(8):e93-e621. DOI: 10.1161/CIR.0000000000001123. View

3.
Han L, Shen S, Wu Y, Zhong C, Zheng X . Trajectories of depressive symptoms and risk of cardiovascular disease: Evidence from the China Health and Retirement Longitudinal Study. J Psychiatr Res. 2021; 145:137-143. DOI: 10.1016/j.jpsychires.2021.12.017. View

4.
Ambrose J, Barua R . The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol. 2004; 43(10):1731-7. DOI: 10.1016/j.jacc.2003.12.047. View

5.
Wium-Andersen M, Wium-Andersen I, Jorgensen M, McGue M, Jorgensen T, Christensen K . The association between depressive mood and ischemic heart disease: a twin study. Acta Psychiatr Scand. 2019; 140(3):265-274. PMC: 8039049. DOI: 10.1111/acps.13072. View